COVID-19: Gastrointestinal Manifestations and Complications
The virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
HH Publisher
2021-11-01
|
Series: | Progress in Microbes and Molecular Biology |
Online Access: | https://journals.hh-publisher.com/index.php/pmmb/article/view/513 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832541393150541824 |
---|---|
author | Angel Yun-Kuan Thye Priyia Pusparajah Loh Teng-Hern Tan Jodi Woan-Fei Law Vengadesh Letchumanan Learn-Han Lee |
author_facet | Angel Yun-Kuan Thye Priyia Pusparajah Loh Teng-Hern Tan Jodi Woan-Fei Law Vengadesh Letchumanan Learn-Han Lee |
author_sort | Angel Yun-Kuan Thye |
collection | DOAJ |
description | The virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The common symptoms of COVID-19 infection are fever and respiratory symptoms, but it can also involve the gastrointestinal tract (GIT), resulting in manifestations such as diarrhea, nausea and/or vomiting and abdominal pain. The emergence of COVID-19 led to public health emphasis on droplet transmission and precautions of contact with respiratory secretions. However, mounting evidence demonstrates detection of SARS-CoV-2 RNA in stool samples of COVID-19 patients. It has also been demonstrated that the host receptor angiotensin-converting-enzyme-2 (ACE-2) is highly expressed not just in respiratory cells but also in gastrointestinal sites involving the glandular cells of gastric, duodenal, and rectal epithelium. This suggests that SARS-CoV-2 can infect the digestive system, serving as another route of transmission. This review aims to study the prevalence of some of the gastrointestinal manifestations following COVID-19 infection and findings of positive SARS-CoV-2 RNA in stool specimens while making parallels to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) infection. We will also discuss the possible pathophysiology of COVID-19 related gastrointestinal involvement.
|
format | Article |
id | doaj-art-2f19320af06440b7a86afc3f20473205 |
institution | Kabale University |
issn | 2637-1049 |
language | English |
publishDate | 2021-11-01 |
publisher | HH Publisher |
record_format | Article |
series | Progress in Microbes and Molecular Biology |
spelling | doaj-art-2f19320af06440b7a86afc3f204732052025-02-04T08:40:11ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492021-11-014110.36877/pmmb.a0000247COVID-19: Gastrointestinal Manifestations and ComplicationsAngel Yun-Kuan ThyePriyia PusparajahLoh Teng-Hern TanJodi Woan-Fei LawVengadesh LetchumananLearn-Han LeeThe virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The common symptoms of COVID-19 infection are fever and respiratory symptoms, but it can also involve the gastrointestinal tract (GIT), resulting in manifestations such as diarrhea, nausea and/or vomiting and abdominal pain. The emergence of COVID-19 led to public health emphasis on droplet transmission and precautions of contact with respiratory secretions. However, mounting evidence demonstrates detection of SARS-CoV-2 RNA in stool samples of COVID-19 patients. It has also been demonstrated that the host receptor angiotensin-converting-enzyme-2 (ACE-2) is highly expressed not just in respiratory cells but also in gastrointestinal sites involving the glandular cells of gastric, duodenal, and rectal epithelium. This suggests that SARS-CoV-2 can infect the digestive system, serving as another route of transmission. This review aims to study the prevalence of some of the gastrointestinal manifestations following COVID-19 infection and findings of positive SARS-CoV-2 RNA in stool specimens while making parallels to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) infection. We will also discuss the possible pathophysiology of COVID-19 related gastrointestinal involvement. https://journals.hh-publisher.com/index.php/pmmb/article/view/513 |
spellingShingle | Angel Yun-Kuan Thye Priyia Pusparajah Loh Teng-Hern Tan Jodi Woan-Fei Law Vengadesh Letchumanan Learn-Han Lee COVID-19: Gastrointestinal Manifestations and Complications Progress in Microbes and Molecular Biology |
title | COVID-19: Gastrointestinal Manifestations and Complications |
title_full | COVID-19: Gastrointestinal Manifestations and Complications |
title_fullStr | COVID-19: Gastrointestinal Manifestations and Complications |
title_full_unstemmed | COVID-19: Gastrointestinal Manifestations and Complications |
title_short | COVID-19: Gastrointestinal Manifestations and Complications |
title_sort | covid 19 gastrointestinal manifestations and complications |
url | https://journals.hh-publisher.com/index.php/pmmb/article/view/513 |
work_keys_str_mv | AT angelyunkuanthye covid19gastrointestinalmanifestationsandcomplications AT priyiapusparajah covid19gastrointestinalmanifestationsandcomplications AT lohtengherntan covid19gastrointestinalmanifestationsandcomplications AT jodiwoanfeilaw covid19gastrointestinalmanifestationsandcomplications AT vengadeshletchumanan covid19gastrointestinalmanifestationsandcomplications AT learnhanlee covid19gastrointestinalmanifestationsandcomplications |